[HTML][HTML] Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention

LM Butler, Y Perone, J Dehairs, LE Lupien… - Advanced drug delivery …, 2020 - Elsevier
With the advent of effective tools to study lipids, including mass spectrometry-based
lipidomics, lipids are emerging as central players in cancer biology. Lipids function as …

Oxidative stress response and Nrf2 signaling in aging

H Zhang, KJA Davies, HJ Forman - Free Radical Biology and Medicine, 2015 - Elsevier
Increasing oxidative stress, a major characteristic of aging, has been implicated in a variety
of age-related pathologies. In aging, oxidant production from several sources is increased …

c-Myc and cancer metabolism

DM Miller, SD Thomas, A Islam, D Muench… - Clinical cancer …, 2012 - AACR
The processes of cellular growth regulation and cellular metabolism are closely interrelated.
The c-Myc oncogene is a “master regulator” which controls many aspects of both of these …

HDAC and PI3K antagonists cooperate to inhibit growth of MYC-driven medulloblastoma

Y Pei, KW Liu, J Wang, A Garancher, R Tao… - Cancer cell, 2016 - cell.com
Medulloblastoma (MB) is a highly malignant pediatric brain tumor. Despite aggressive
therapy, many patients succumb to the disease, and survivors experience severe side …

Cholesterol and beyond-The role of the mevalonate pathway in cancer biology

A Göbel, M Rauner, LC Hofbauer… - Biochimica et Biophysica …, 2020 - Elsevier
Cancer is a multifaceted global disease. Transformation of a normal to a malignant cell takes
several steps, including somatic mutations, epigenetic alterations, metabolic reprogramming …

[HTML][HTML] Statin treatment-induced development of type 2 diabetes: from clinical evidence to mechanistic insights

U Galicia-Garcia, S Jebari, A Larrea-Sebal… - International Journal of …, 2020 - mdpi.com
Statins are the gold-standard treatment for the prevention of primary and secondary
cardiovascular disease, which is the leading cause of mortality worldwide. Despite the safety …

The innovative potential of statins in cancer: new targets for new therapies

E Di Bello, C Zwergel, A Mai, S Valente - Frontiers in chemistry, 2020 - frontiersin.org
Numerous and different types of cancers possess the dysregulation of the mevalonate
pathway as a common feature. Statins, traditionally applied in cardiovascular diseases to …

Targeting the mevalonate pathway in cancer

D Juarez, DA Fruman - Trends in cancer, 2021 - cell.com
The mevalonate synthesis inhibitors, statins, are mainstay therapeutics for cholesterol
management and cardiovascular health. Thirty years of research have uncovered supportive …

Role of MYC in Medulloblastoma

MF Roussel, GW Robinson - Cold Spring …, 2013 - perspectivesinmedicine.cshlp.org
Since its discovery as an oncogene carried by the avian acute leukemia virus MC29 in
myelocytomatosis and its cloning, c-MYC (MYC), as well as its paralogs MYCN and MYCL1 …

Beyond aspirin—cancer prevention with statins, metformin and bisphosphonates

N Gronich, G Rennert - Nature reviews Clinical oncology, 2013 - nature.com
Cancer risk reduction using pharmacological means is an attractive modern preventive
approach that supplements the classical behavioural prevention recommendations …